{"id":"https://openalex.org/W2104935570","doi":"https://doi.org/10.1111/j.1365-2125.2012.04297.x","title":"How biologics targeting the IL\u20101 system are being considered for the treatment of type 2 diabetes","display_name":"How biologics targeting the IL\u20101 system are being considered for the treatment of type 2 diabetes","alternate_titles":[],"publication_year":2013,"publication_date":"2013-07-23","ids":{"openalex":"https://openalex.org/W2104935570","doi":"https://doi.org/10.1111/j.1365-2125.2012.04297.x","mag":"2104935570","pmid":"https://pubmed.ncbi.nlm.nih.gov/22506644","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3731600"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2125.2012.04297.x","doi":"https://doi.org/10.1111/j.1365-2125.2012.04297.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2012.04297.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2012.04297.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2104935570"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2012.04297.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085197434","display_name":"Marianne B\u00f6ni\u2010Schnetzler","orcid":"https://orcid.org/0000-0001-5569-5506","observed_orcids":["https://orcid.org/0000-0001-5569-5506"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Marianne B\u00f6ni\u2010Schnetzler","raw_affiliation_strings":["Clinic for Endocrinology, Diabetes and Metabolism and Department of Biomedicine, University Hospital of Basel, Basel, Switzerland. marianne.boeni@unibas.ch","Clinic for Endocrinology, Diabetes and Metabolism and Department of Biomedicine, University Hospital of Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic for Endocrinology, Diabetes and Metabolism and Department of Biomedicine, University Hospital of Basel, Basel, Switzerland. marianne.boeni@unibas.ch","institution_ids":["https://openalex.org/I2802542264"]},{"raw_affiliation_string":"Clinic for Endocrinology, Diabetes and Metabolism and Department of Biomedicine, University Hospital of Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017674179","display_name":"Marc Yves Donath","orcid":"https://orcid.org/0000-0002-3143-5045","observed_orcids":["https://orcid.org/0000-0002-3143-5045"]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marc Y. Donath","raw_affiliation_strings":["Clinic for Endocrinology, Diabetes and Metabolism and Department of Biomedicine, University Hospital of Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic for Endocrinology, Diabetes and Metabolism and Department of Biomedicine, University Hospital of Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5085197434"],"corresponding_institution_ids":["https://openalex.org/I2802542264"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.7855,"has_fulltext":true,"cited_by_count":49,"citation_normalized_percentile":{"value":0.59699248,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"76","issue":"2","first_page":"263","last_page":"268"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7182999849319458,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.7182999849319458,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.24079999327659607,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9940000176429749},{"id":"https://openalex.org/keywords/interleukin-1","display_name":"interleukin-1","score":0.8489999771118164},{"id":"https://openalex.org/keywords/interleukin-1-receptor-antagonist","display_name":"interleukin-1 receptor antagonist","score":0.8379999995231628},{"id":"https://openalex.org/keywords/insulitis","display_name":"insulitis","score":0.6549999713897705},{"id":"https://openalex.org/keywords/beta-cell-dysfunction","display_name":"beta-cell dysfunction","score":0.8169999718666077},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.8880000114440918},{"id":"https://openalex.org/keywords/systemic-inflammation","display_name":"systemic inflammation","score":0.6010000109672546},{"id":"https://openalex.org/keywords/cytokine-therapy","display_name":"cytokine therapy","score":0.7379999756813049},{"id":"https://openalex.org/keywords/innate-immunity","display_name":"innate immunity","score":0.5080000162124634}],"concepts":[{"id":"https://openalex.org/C165220095","wikidata":"https://www.wikidata.org/wiki/Q207524","display_name":"Islet","level":3,"score":0.7280476093292236},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6663897037506104},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.65045166015625},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6412165760993958},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6164750456809998},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5266358852386475},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5070364475250244},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.48799437284469604},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.48646900057792664},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.475273072719574},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4650712013244629},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.45371493697166443},{"id":"https://openalex.org/C2776828364","wikidata":"https://www.wikidata.org/wiki/Q1767180","display_name":"Beta cell","level":4,"score":0.4431934952735901},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44296497106552124}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007375","descriptor_name":"Interleukin-1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D019138","descriptor_name":"Antibodies, Blocking","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D053590","descriptor_name":"Interleukin 1 Receptor Antagonist Protein","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1365-2125.2012.04297.x","doi":"https://doi.org/10.1111/j.1365-2125.2012.04297.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2012.04297.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2012.04297.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3482598","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3731600","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3731600","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3731600/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:22506644","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22506644","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2125.2012.04297.x","doi":"https://doi.org/10.1111/j.1365-2125.2012.04297.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2012.04297.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2012.04297.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2104935570.pdf","grobid_xml":"https://content.openalex.org/works/W2104935570.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W1493025774","https://openalex.org/W1518684923","https://openalex.org/W1546304862","https://openalex.org/W1965435514","https://openalex.org/W1966344654","https://openalex.org/W1966977991","https://openalex.org/W1972483153","https://openalex.org/W1976595941","https://openalex.org/W1990902267","https://openalex.org/W1998420980","https://openalex.org/W2008869160","https://openalex.org/W2018607502","https://openalex.org/W2024378513","https://openalex.org/W2024992738","https://openalex.org/W2034946303","https://openalex.org/W2037884311","https://openalex.org/W2038295319","https://openalex.org/W2039664878","https://openalex.org/W2045362322","https://openalex.org/W2048211245","https://openalex.org/W2048755332","https://openalex.org/W2051303794","https://openalex.org/W2053369310","https://openalex.org/W2074115529","https://openalex.org/W2074685860","https://openalex.org/W2076327713","https://openalex.org/W2076633494","https://openalex.org/W2092084431","https://openalex.org/W2097722989","https://openalex.org/W2100271953","https://openalex.org/W2104919659","https://openalex.org/W2112620654","https://openalex.org/W2113145530","https://openalex.org/W2115871198","https://openalex.org/W2115896586","https://openalex.org/W2118968774","https://openalex.org/W2120763335","https://openalex.org/W2124848390","https://openalex.org/W2126985857","https://openalex.org/W2136024338","https://openalex.org/W2137334382","https://openalex.org/W2137983259","https://openalex.org/W2150107812","https://openalex.org/W2150367899","https://openalex.org/W2150702412","https://openalex.org/W2157495503","https://openalex.org/W2161257972","https://openalex.org/W2166696315","https://openalex.org/W2411826498","https://openalex.org/W3022401702","https://openalex.org/W4211217520","https://openalex.org/W4240175730"],"related_works":["https://openalex.org/W1803405992","https://openalex.org/W2133891847","https://openalex.org/W188289591","https://openalex.org/W2043784314","https://openalex.org/W2079772717","https://openalex.org/W2108416978","https://openalex.org/W6989337331","https://openalex.org/W2097722989"],"abstract_inverted_index":{"Metabolic":[0],"diseases":[1],"are":[2,34,96],"associated":[3],"with":[4,62,82,84],"activation":[5],"of":[6,23,79],"the":[7,21,59,63],"innate":[8],"immune":[9,24],"system":[10,61],"in":[11,36,76,99],"various":[12],"tissues":[13],"and":[14,20,52,54,72,91,102],"characterized":[15],"by":[16],"elevated":[17],"inflammatory":[18],"factors":[19],"presence":[22],"cells.":[25],"Type":[26],"2":[27,86,113],"diabetes":[28],"develops":[29],"when":[30],"islet":[31,56],"beta":[32,49],"cells":[33],"deficient":[35],"producing":[37],"sufficient":[38],"insulin":[39,43,69],"to":[40,106],"overcome":[41],"peripheral":[42],"resistance.":[44],"Intra-islet":[45],"IL-1\u03b2":[46,93],"activity":[47],"diminishes":[48],"cell":[50],"function":[51],"survival":[53],"governs":[55],"inflammation.":[57],"Targeting":[58],"IL-1":[60,64],"receptor":[65],"antagonist":[66],"IL1Ra":[67],"improved":[68],"secretion,":[70],"glycaemia":[71],"reduced":[73],"systemic":[74],"inflammation":[75],"a":[77,107],"proof":[78],"concept":[80],"study":[81],"patients":[83],"type":[85,112],"diabetes.":[87,114],"Currently,":[88],"long":[89],"lasting":[90],"specific":[92],"blocking":[94],"antibodies":[95],"being":[97],"evaluated":[98],"clinical":[100],"trials":[101],"this":[103],"may":[104],"lead":[105],"novel":[108],"cytokine-based":[109],"treatment":[110],"for":[111]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2104935570","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
